On 22nd January 2026, ERA4TB will host the next session in its ongoing webinar series on the intersection of clinical research, health economics, and policy.
This event, which has been made in collaboration with the National Institute for Health Care and Excellence (NICE) and Consiglio Nazionale delle Rierche (CNR), will focus on model-informed early-phase development and assessment of TBAJ-587.
With TBAJ-587 currently in Phase 1, this webinar will explore how innovative translational and simulation approaches can bridge scientific discovery with real-world decision-making.
The session will also feature how in-silico evidence can enhance early regulatory and HTA evaluations, offering insights with impact well beyond tuberculosis (TB).
Guest speakers:
Evangelos Karakitsios, Post Doctoral Researcher
(Consiglio Nazionale delle Ricerche)
Alessandro di Deo, Post Doctoral Researcher
(Consiglio Nazionale delle Ricerche)
Steve Sharp, Scientific Adviser
(NICE – National Institute for Health and Care Excellence)
Michael Bell, Senior Analyst
(NICE – National Institute for Health and Care Excellence)
Participants will gain:
- Insights into the progress of TBAJ-587 and from the UK national HTA regulatory body, NICE
- An understanding of how in-silico evidence can enhance early regulatory and HTA evaluations
- The opportunity to join a live Q&A with leading voices in early phase TB drug development and NICE’s HTA Lab
To join the session, please register via the link below:
